TreeWAS – Variant ID: rs1775154

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R63.1 Polydipsia	0.127	0.873	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.075	0.925	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.069	0.931	0.000
Y45.1 Salicylates	0.067	0.933	0.000
Y45.2 Propionic acid derivatives	0.064	0.936	0.000
C18.9 Colon, unspecified	0.000	0.942	0.058
C18 Malignant neoplasm of colon	0.000	0.944	0.056
C18.0 Caecum	0.000	0.944	0.056
Y45.4 Antirheumatics	0.053	0.947	0.000
Y45.8 Other analgesics and antipyretics	0.051	0.949	0.000
C18.2 Ascending colon	0.000	0.949	0.051
C18.1 Appendix	0.000	0.950	0.050
C18.5 Splenic flexure	0.000	0.950	0.050
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.048	0.952	0.000
Y45.5 4-Aminophenol derivatives	0.047	0.953	0.000
C18.4 Transverse colon	0.000	0.954	0.046
Y45.0 Opioids and related analgesics	0.044	0.956	0.000
C18.8 Overlapping lesion of colon	0.000	0.963	0.037
C18.7 Sigmoid colon	0.000	0.964	0.036
C18.3 Hepatic flexure	0.000	0.969	0.031
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.975	0.025
K85.1 Biliary acute pancreatitis	0.000	0.977	0.023
Z96.0 Presence of urogenital implants	0.000	0.982	0.018
K85 Acute pancreatitis	0.000	0.983	0.017
K85.9 Acute pancreatitis, unspecified	0.000	0.984	0.016
M47.12 Other spondylosis with myelopathy (Cervical region)	0.000	0.984	0.016
N87.1 Moderate cervical dysplasia	0.015	0.985	0.000
K85.0 Idiopathic acute pancreatitis	0.000	0.986	0.014
M47.9 Spondylosis, unspecified	0.000	0.987	0.013
M47.1 Other spondylosis with myelopathy	0.000	0.987	0.013
K85.2 Alcohol-induced acute pancreatitis	0.000	0.987	0.013
M47.94 Spondylosis, unspecified (Thoracic region)	0.000	0.987	0.013
K85.8 Other acute pancreatitis	0.000	0.987	0.012
C18.6 Descending colon	0.000	0.988	0.012
K85.3 Drug-induced acute pancreatitis	0.000	0.988	0.012
M47.92 Spondylosis, unspecified (Cervical region)	0.000	0.989	0.011
M47 Spondylosis	0.000	0.989	0.011
M47.16 Other spondylosis with myelopathy (Lumbar region)	0.000	0.990	0.010
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.990	0.010
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.000	0.990	0.010
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.000	0.990	0.010
M47.19 Other spondylosis with myelopathy (Site unspecified)	0.000	0.990	0.010
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)	0.000	0.990	0.010
M47.17 Other spondylosis with myelopathy (Lumbosacral region)	0.000	0.990	0.010
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)	0.000	0.990	0.010
M47.14 Other spondylosis with myelopathy (Thoracic region)	0.000	0.990	0.010
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)	0.000	0.990	0.010
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)	0.000	0.990	0.010
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)	0.000	0.990	0.010
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.000	0.991	0.009
R74.8 Abnormal levels of other serum enzymes	0.000	0.991	0.009
Z39.0 Care and examination immediately after delivery	0.000	0.992	0.008
M47.0 Anterior spinal and vertebral artery compression syndromes	0.000	0.992	0.008
Z39.1 Care and examination of lactating mother	0.000	0.992	0.008
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.000	0.992	0.007
K31.8 Other specified diseases of stomach and duodenum	0.000	0.993	0.007
Z39 Postpartum care and examination	0.000	0.993	0.007
M47.2 Other spondylosis with radiculopathy	0.000	0.993	0.007
O62.2 Other uterine inertia	0.000	0.993	0.007
S52.00 Fracture of upper end of ulna (closed)	0.007	0.993	0.000
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.000	0.993	0.007
K26.4 Chronic or unspecified with haemorrhage	0.007	0.993	0.000
Z39.2 Routine postpartum follow-up	0.000	0.994	0.006
N87 Dysplasia of cervix uteri	0.006	0.994	0.000
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)	0.000	0.994	0.006
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)	0.000	0.994	0.006
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)	0.000	0.994	0.006
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)	0.000	0.994	0.006
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)	0.000	0.994	0.006
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)	0.000	0.994	0.006
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)	0.000	0.994	0.006
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)	0.000	0.994	0.006
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)	0.000	0.994	0.006
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)	0.000	0.994	0.006
N87.2 Severe cervical dysplasia, not elsewhere classified	0.006	0.994	0.000
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.000	0.995	0.005
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.000	0.995	0.005
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.000	0.995	0.005
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.000	0.995	0.005
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.000	0.995	0.005
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.000	0.995	0.005
I84.7 Unspecified thrombosed haemorrhoids	0.005	0.995	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
S52.0 Fracture of upper end of ulna	0.005	0.995	0.000
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)	0.000	0.995	0.005
S52.01 Fracture of upper end of ulna (open)	0.005	0.995	0.000
I44.3 Other and unspecified atrioventricular block	0.000	0.995	0.005
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.995	0.005
R74 Abnormal serum enzyme levels	0.000	0.995	0.005
D52.9 Folate deficiency anaemia, unspecified	0.005	0.995	0.000
S91.3 Open wound of other parts of foot	0.000	0.995	0.005
N87.0 Mild cervical dysplasia	0.004	0.996	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.000	0.996	0.004
Y40.0 Penicillins	0.004	0.996	0.000
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.000	0.996	0.004
G93.3 Postviral fatigue syndrome	0.000	0.996	0.004
C62.1 Descended testis	0.000	0.996	0.004
O62.0 Primary inadequate contractions	0.000	0.996	0.004
C62.9 Testis, unspecified	0.000	0.996	0.004
R74.0 Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]	0.000	0.996	0.004
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.000	0.996	0.004
R74.9 Abnormal level of unspecified serum enzyme	0.000	0.996	0.004
N08.3 Glomerular disorders in diabetes mellitus	0.004	0.996	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.996	0.004
C62 Malignant neoplasm of testis	0.000	0.996	0.004
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
C53.9 Cervix uteri, unspecified	0.003	0.996	0.000
I77.6 Arteritis, unspecified	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
N02 Recurrent and persistent haematuria	0.003	0.997	0.000
O62 Abnormalities of forces of labour	0.000	0.997	0.003
T81.5 Foreign body accidentally left in body cavity or operation wound following a procedure	0.003	0.997	0.000
L85.8 Other specified epidermal thickening	0.000	0.997	0.003
N08 Glomerular disorders in diseases classified elsewhere	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
N87.9 Dysplasia of cervix uteri, unspecified	0.003	0.997	0.000
N02.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.997	0.003
H21.5 Other adhesions and disruptions of iris and ciliary body	0.003	0.997	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
M84.48 Pathological fracture, not elsewhere classified (Other)	0.003	0.997	0.000
N00-N08 Glomerular diseases	0.003	0.997	0.000
N02.0 Minor glomerular abnormality	0.003	0.997	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.003	0.997	0.000
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
M84.41 Pathological fracture, not elsewhere classified (Shoulder region)	0.003	0.997	0.000
C62.0 Undescended testis	0.000	0.997	0.003
N02.8 Other	0.003	0.997	0.000
M84.4 Pathological fracture, not elsewhere classified	0.003	0.997	0.000
T78.4 Allergy, unspecified	0.003	0.997	0.000
N02.9 Unspecified	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
N04 Nephrotic syndrome	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
N04.9 Unspecified	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N02.6 Dense deposit disease	0.003	0.997	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N02.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
L29.2 Pruritus vulvae	0.003	0.997	0.000
O62.8 Other abnormalities of forces of labour	0.000	0.997	0.003
R56.8 Other and unspecified convulsions	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
M84.42 Pathological fracture, not elsewhere classified (Upper arm)	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.003	0.997	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.003	0.997	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.003	0.997	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
D26.1 Corpus uteri	0.000	0.997	0.003
Z99.3 Dependence on wheelchair	0.000	0.997	0.003
Y58 Bacterial vaccines	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
B17.1 Acute hepatitis C	0.003	0.997	0.000
N05 Unspecified nephritic syndrome	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
M84.45 Pathological fracture, not elsewhere classified (Pelvic region and thigh)	0.002	0.997	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.997	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.003	0.997	0.000
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.000	0.998	0.002
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.002	0.998	0.000
N06 Isolated proteinuria with specified morphological lesion	0.002	0.998	0.000
N01 Rapidly progressive nephritic syndrome	0.002	0.998	0.000
N00 Acute nephritic syndrome	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
O62.9 Abnormality of forces of labour, unspecified	0.000	0.998	0.002
Y40.5 Aminoglycosides	0.002	0.998	0.000
C53 Malignant neoplasm of cervix uteri	0.002	0.998	0.000
M84.49 Pathological fracture, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
M84.47 Pathological fracture, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
M84.46 Pathological fracture, not elsewhere classified (Lower leg)	0.002	0.998	0.000
M84.44 Pathological fracture, not elsewhere classified (Hand)	0.002	0.998	0.000
M84.43 Pathological fracture, not elsewhere classified (Forearm)	0.002	0.998	0.000
M84.40 Pathological fracture, not elsewhere classified (Multiple sites)	0.002	0.998	0.000
O62.3 Precipitate labour	0.000	0.998	0.002
N05.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
N04.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N04.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
N04.8 Other	0.002	0.998	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N04.6 Dense deposit disease	0.002	0.998	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
M79.18 Myalgia (Other)	0.000	0.998	0.002
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.000	0.998	0.002
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
K55.0 Acute vascular disorders of intestine	0.002	0.998	0.000
O62.1 Secondary uterine inertia	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
C61 Malignant neoplasm of prostate	0.000	0.998	0.002
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.002	0.998	0.000
G82.5 Tetraplegia, unspecified	0.000	0.998	0.002
D52 Folate deficiency anaemia	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
N04.0 Minor glomerular abnormality	0.002	0.998	0.000
N05.6 Dense deposit disease	0.002	0.998	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N05.0 Minor glomerular abnormality	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
N05.8 Other	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
K12.1 Other forms of stomatitis	0.000	0.998	0.002
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.000	0.998	0.002
G82.2 Paraplegia, unspecified	0.000	0.998	0.002
I49.0 Ventricular fibrillation and flutter	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
R16.1 Splenomegaly, not elsewhere classified	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
M79.28 Neuralgia and neuritis, unspecified (Other)	0.000	0.998	0.002
N00.9 Unspecified	0.002	0.998	0.000
N00.8 Other	0.002	0.998	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N00.6 Dense deposit disease	0.002	0.998	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N00.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N00.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N00.0 Minor glomerular abnormality	0.002	0.998	0.000
N01.9 Unspecified	0.002	0.998	0.000
N01.8 Other	0.002	0.998	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N01.6 Dense deposit disease	0.002	0.998	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N01.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N01.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N01.0 Minor glomerular abnormality	0.002	0.998	0.000
N06.9 Unspecified	0.002	0.998	0.000
N06.8 Other	0.002	0.998	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N06.6 Dense deposit disease	0.002	0.998	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N06.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N06.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N06.0 Minor glomerular abnormality	0.002	0.998	0.000
N07.9 Unspecified	0.002	0.998	0.000
N07.8 Other	0.002	0.998	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N07.6 Dense deposit disease	0.002	0.998	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N07.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N07.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N07.0 Minor glomerular abnormality	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
C60-C63 Malignant neoplasms of male genital organs	0.000	0.998	0.002
C53.8 Overlapping lesion of cervix uteri	0.002	0.998	0.000
C53.1 Exocervix	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
C53.0 Endocervix	0.002	0.998	0.000
F99 Mental disorder, not otherwise specified	0.002	0.998	0.000
D59.1 Other autoimmune haemolytic anaemias	0.002	0.998	0.000
E85.4 Organ-limited amyloidosis	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
M79.2 Neuralgia and neuritis, unspecified	0.000	0.998	0.002
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
B17 Other acute viral hepatitis	0.002	0.998	0.000
M79.20 Neuralgia and neuritis, unspecified (Multiple sites)	0.000	0.998	0.002
K12.0 Recurrent oral aphthae	0.000	0.998	0.002
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
D10.1 Tongue	0.000	0.998	0.002
R45.1 Restlessness and agitation	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
R63 Symptoms and signs concerning food and fluid intake	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.998	0.002
N48.8 Other specified disorders of penis	0.000	0.998	0.002
R49.8 Other and unspecified voice disturbances	0.002	0.998	0.000
K26 Duodenal ulcer	0.002	0.998	0.000
N03 Chronic nephritic syndrome	0.002	0.998	0.000
E22.0 Acromegaly and pituitary gigantism	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
S52 Fracture of forearm	0.002	0.998	0.000
B17.9 Acute viral hepatitis, unspecified	0.002	0.998	0.000
D52.8 Other folate deficiency anaemias	0.002	0.998	0.000
D52.1 Drug-induced folate deficiency anaemia	0.002	0.998	0.000
D52.0 Dietary folate deficiency anaemia	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
K12.2 Cellulitis and abscess of mouth	0.000	0.998	0.002
N03.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
M79.26 Neuralgia and neuritis, unspecified (Lower leg)	0.000	0.998	0.002
M79.25 Neuralgia and neuritis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
B17.2 Acute hepatitis E	0.002	0.998	0.000
G54.0 Brachial plexus disorders	0.002	0.998	0.000
S52.4 Fracture of shafts of both ulna and radius	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
M79.23 Neuralgia and neuritis, unspecified (Forearm)	0.000	0.998	0.002
G93.4 Encephalopathy, unspecified	0.002	0.998	0.000
K12 Stomatitis and related lesions	0.000	0.998	0.002
S52.40 Fracture of shafts of both ulna and radius (closed)	0.002	0.998	0.000
N05.9 Unspecified	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
D31.3 Choroid	0.002	0.998	0.000
N05.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
R56.0 Febrile convulsions	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.001	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.001	0.998	0.000
Y48.0 Inhaled anaesthetics	0.001	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
D16.2 Long bones of lower limb	0.002	0.998	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.000	0.998	0.002
N93.8 Other specified abnormal uterine and vaginal bleeding	0.000	0.998	0.002
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
S52.51 Fracture of lower end of radius (open)	0.002	0.998	0.000
S52.2 Fracture of shaft of ulna	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
B19.9 Unspecified viral hepatitis without coma	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.001	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
M79.24 Neuralgia and neuritis, unspecified (Hand)	0.000	0.998	0.002
M79.22 Neuralgia and neuritis, unspecified (Upper arm)	0.000	0.998	0.002
M79.21 Neuralgia and neuritis, unspecified (Shoulder region)	0.000	0.998	0.002
K26.2 Acute with both haemorrhage and perforation	0.002	0.998	0.000
C52 Malignant neoplasm of vagina	0.002	0.998	0.000
G82 Paraplegia and tetraplegia	0.000	0.998	0.002
Z08 Follow-up examination after treatment for malignant neoplasm	0.000	0.998	0.002
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.998	0.002
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.002	0.998	0.000
N03.8 Other	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.001	0.998	0.000
Z49.2 Other dialysis	0.000	0.998	0.002
B59 Pneumocystosis	0.000	0.998	0.002
S52.20 Fracture of shaft of ulna (closed)	0.002	0.998	0.000
R63.6 Insufficient intake of food and water due to self neglect	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.998	0.000
R63.2 Polyphagia	0.001	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
Y51.0 Anticholinesterase agents	0.001	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.998	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.000	0.998	0.001
N19 Unspecified renal failure	0.000	0.998	0.002
R56 Convulsions, not elsewhere classified	0.002	0.998	0.000
C80.9 Malignant neoplasm, unspecified	0.002	0.998	0.000
I44.2 Atrioventricular block, complete	0.000	0.998	0.002
K26.1 Acute with perforation	0.002	0.998	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.001	0.998	0.000
N03.6 Dense deposit disease	0.001	0.998	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.001	0.998	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.001	0.998	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.001	0.998	0.000
N03.2 Diffuse membranous glomerulonephritis	0.001	0.998	0.000
N03.0 Minor glomerular abnormality	0.001	0.998	0.000
Q18.1 Preauricular sinus and cyst	0.000	0.998	0.002
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.998	0.000
S30.2 Contusion of external genital organs	0.002	0.998	0.000
S52.9 Fracture of forearm, part unspecified	0.001	0.998	0.000
Y41.0 Sulphonamides	0.001	0.998	0.000
C45.0 Mesothelioma of pleura	0.002	0.998	0.000
C71.2 Temporal lobe	0.000	0.998	0.002
Q21.1 Atrial septal defect	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.001	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.000	0.998	0.002
B17.8 Other specified acute viral hepatitis	0.001	0.998	0.000
F43.0 Acute stress reaction	0.000	0.998	0.002
K26.0 Acute with haemorrhage	0.002	0.998	0.000
S52.41 Fracture of shafts of both ulna and radius (open)	0.001	0.998	0.000
Q87.4 Marfan's syndrome	0.000	0.998	0.001
S52.7 Multiple fractures of forearm	0.001	0.998	0.000
S52.3 Fracture of shaft of radius	0.001	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.998	0.000
K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified	0.002	0.998	0.000
K12.3 Oral mucositis (ulcerative)	0.000	0.998	0.002
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.998	0.000
S30.0 Contusion of lower back and pelvis	0.001	0.998	0.000
Y44.2 Anticoagulants	0.001	0.998	0.000
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.001	0.998	0.000
D21.2 Connective and other soft tissue of lower limb, including hip	0.001	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.998	0.000
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)	0.000	0.999	0.001
C45.9 Mesothelioma, unspecified	0.001	0.999	0.000
G82.3 Flaccid tetraplegia	0.000	0.999	0.001
G82.0 Flaccid paraplegia	0.000	0.999	0.001
D26.9 Uterus, unspecified	0.000	0.999	0.001
G82.1 Spastic paraplegia	0.000	0.999	0.001
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.999	0.000
S52.21 Fracture of shaft of ulna (open)	0.001	0.999	0.000
S92.70 Multiple fractures of foot (closed)	0.001	0.999	0.000
C63.9 Male genital organ, unspecified	0.000	0.999	0.001
C63.8 Overlapping lesion of male genital organs	0.000	0.999	0.001
C63.7 Other specified male genital organs	0.000	0.999	0.001
C63.1 Spermatic cord	0.000	0.999	0.001
C63.0 Epididymis	0.000	0.999	0.001
E85.9 Amyloidosis, unspecified	0.001	0.999	0.000
I65.2 Occlusion and stenosis of carotid artery	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations